EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-phase compositions for an initial and delayed release of a vaginal medicament



Multi-phase compositions for an initial and delayed release of a vaginal medicament



Official Gazette of the United States Patent & Trademark Office Patents 1228(3), Nov 16



The present invention relates to multi-phase compositions for treating vaginal infections, for example, infections caused by Trichomonas vaginitis. The compositions, which are preferably formulated as a cream or pessary, comprise a continuous phase containing anti-vaginitis medicament for rapid, initial release and porous particles adapted for the delayed release of anti-vaginitis medicaments. Metronidazole is the preferred anti-trichomal medicament.

(PDF 0-2 workdays service: $29.90)

Accession: 035349405

Download citation: RISBibTeXText



Related references

The accuracy of derived plagioclase compositions from multi-component, multi-phase sand mixtures; implications for determining Martian plagioclase compositions. Abstracts of Papers Submitted to the Lunar and Planetary Science Conference 37: (unpaginated, 2006

Medicament with a delayed release of active ingredient us patent 4795643 january 3 1989. Official Gazette of the United States Patent & Trademark Office Patents 1098(1): 352, 1989

Delayed release flavorant compositions. Official Gazette of the United States Patent & Trademark Office Patents 1224(2), Jul 13, 1999

Medicament release from ointment bases ii. testosterone in vitro release and effects of additives on its release. Drug Development and Industrial Pharmacy 12(14): 2493-2510, 1986

Controlled release liquid delivery compositions with low initial drug burst. Official Gazette of the United States Patent & Trademark Office Patents 1240(1), Nov 7, 2000

The regularities of variability of kimberlite compositions in multi-phase pipes. Proceedings of the International Kimberlite Conference 5: 523-524, 1991

Medicament compositions containing anticholinergically-effective compounds and salmeterol. Official Gazette of the United States Patent & Trademark Office Patents 1275(1), Oct 7, 2003

Delayed-release Multi Matrix System (MMX (TM)) mesalazine. 2007

Peptide conjugates derived from thymic hormones, their use as a medicament and compositions containing them. Official Gazette of the United States Patent & Trademark Office Patents 1245(1), Apr 3, 2001

Medicament compositions based on tiotropium bromide and formoterol fumarate. Official Gazette of the United States Patent & Trademark Office Patents 1261(2), Aug 13, 2002

Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing them. Official Gazette of the United States Patent & Trademark Office Patents 1264(3), Nov 19, 2002

Medicament compositions based on anticholinergically-effective compounds and beta-mimetics. Official Gazette of the United States Patent & Trademark Office Patents 1262(4), Sep 24, 2002

Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane. Official Gazette of the United States Patent & Trademark Office Patents 1276(1), Nov 4, 2003

Medicament release from ointment bases 1. indomethacin in vitro and in vivo release studies. Drug Development and Industrial Pharmacy 10(7): 1071-1084, 1984

Medicament release from ointment bases iii. ibuprofen in vitro release and in vivo absorption in rabbits. Drug Development and Industrial Pharmacy 12(14): 2521-2540, 1986